---
title: "Olema Pharmaceuticals to Join Major Biotech and Oncology Investor Conferences"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/274870790.md"
datetime: "2026-02-04T21:30:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274870790.md)
  - [en](https://longbridge.com/en/news/274870790.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274870790.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/274870790.md) | [繁體中文](https://longbridge.com/zh-HK/news/274870790.md)


# Olema Pharmaceuticals to Join Major Biotech and Oncology Investor Conferences

Olema Pharmaceuticals Inc. will participate in several upcoming investor conferences in February 2026. The company will join the Guggenheim Securities Emerging Outlook: Biotech Summit on February 11, 2026, in New York, NY, and Citi’s 2026 Virtual Oncology Leadership Summit on February 19, 2026. Additionally, Olema will take part in the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 26, 2026, in a virtual format. Live webcasts and recordings of these presentations will be available on Olema’s investor relations website. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9648874-en) on February 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### 相关股票

- [Olema Pharmaceuticals (OLMA.US)](https://longbridge.com/zh-CN/quote/OLMA.US.md)

## 相关资讯与研究

- [Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA](https://longbridge.com/zh-CN/news/278432011.md)
- [Olema Pharmaceuticals Officer Sells Shares](https://longbridge.com/zh-CN/news/278009149.md)
- [SPAC JATT II Acquisition files for a $60 million IPO, targeting biotech and life sciences](https://longbridge.com/zh-CN/news/279094138.md)
- [08:58 ETEchoStor Technologies Acquires Pennant Networks, Expanding Life Sciences & Managed Services Expertise](https://longbridge.com/zh-CN/news/278726590.md)
- [Worldwide Healthcare Trust Publishes February 2026 Monthly Fact Sheet](https://longbridge.com/zh-CN/news/278855796.md)